close icon

Rapid7 ‘s Rapid Decline Plants the Seeds of a Rally

Eight months ago we made a case that Rapid7 investors should not expect the future to resemble the past. The stock was up 492% since February 2016 and was hovering above $53.50 in August, 2019. Without a doubt, the cyber-security industry was and still is enjoying a strong tailwind.

However, Rapid7’s daily chart revealed a worrying Elliott Wave pattern. It convinced us this was not the stock to bet on as a ~50% decline seemed highly likely. We shared our findings with readers on August 24th, 2019. Take a look below to refresh your memory.

Rapid7 seemed vulnerable eight month ago

The pattern in question was a five-wave impulse, labeled 1-2-3-4-5. The sub-waves of waves 3 and 5 were also visible. In addition, waves 2 and 4 obeyed the rule of alternation. Wave 2 as a flat correction, while wave 4 – a zigzag.

According to the theory, a three-wave correction follows every impulse. This meant that instead of buying the dip from $66 to $53, investors would be better off watching from a safe distance. A decline to the support area of wave 4 near $30 a share made a lot of sense in the summer of 2019. The updated chart below shows how things went.

The dip from $66 kept on until wave A reached a bottom at $42.83 in early-October, 2019. Then wave B gave the bulls plenty of false hopes by lifting the price to $64.26 in January, 2020. Whether wave C coincided with or was caused by the COVID-19 epidemic is hard to tell.

What matters is that it dragged Rapid7 stock to as low as $31.34 on March 16th. From the top of wave 5 to the bottom of wave C, the company lost 52.5% in market value. The good news is the 5-3 wave cycle looks complete now.

If this count is correct, the uptrend which had been in progress prior to July 2019 can be expected to resume. In the long-term, the wave structure suggests a new all-time high is on the cards. However, Rapid7 remains a money-losing company. Prospective investors must make sure they understand the risks associated with the specific business.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

DraftKings on the Verge of Another 40% Decline

It’s been almost three and a half months since we examined DraftKings stock in October, 2020. The share price was hovering near $57 after a strong run from $10.60 to over $64 in just several months. The regulatory environment in the U.S. seemed to be warming up and many analysts hurried to issue their BUY…

Read More »

AMN Healthcare Stock to Suffer a 2020-Like Drop

AMN Healthcare Services provides workforce and staffing solutions to healthcare facilities in the U.S. The company is relatively small with a market capitalization of less than $4 billion. However, small companies can make for excellent returns if one happens to identify the winners. And indeed, between late-2011 and early-2020, AMN stock from under $4 to…

Read More »

Zoetis Stock Getting Ahead of Itself, Invites Correction

Based in Parsippany, NJ, Zoetis Inc. is an animal medicine and vaccine developer and manufacturer. The company went public in 2013 and has been enjoying steady growth since. With the stock currently above $160 a share, Zoetis holds a market cap of nearly $80 billion. For a profitable and growing company like Zoetis, a rising…

Read More »

CBOE Stock Looking Good After a Record Year

CBOE Global Markets Inc. is an equities, options and futures exchange operator in the U.S. and Europe. The company traces its roots back to Chicago in 1973, when it practically invented options trading in its present form. CBOE is literally part of the very infrastructure of modern financial markets. So it is not surprising that…

Read More »

Novo Nordisk Bulls Have an Elliott Wave Problem

Novo Nordisk A/S is a Danish pharmaceuticals major with a market cap of over $160 billion. People need their medication even in recessions, so the company’s business wasn’t as affected by the 2020 crisis as most other industries. Novo Nordisk remains a top-notch pharma with consistent profits and revenue and no debt whatsoever. And the…

Read More »

Lockheed ‘s Correction Still Unfolding as Expected

Almost a year and a half ago, in July 2019, we wrote that Lockheed Martin is likely “setting the stage for an unpleasant surprise.” The stock had just reached a new all-time high and was trading at $370 a share. Optimism was in the air and analysts were more bullish than ever. An indeed, fundamentally,…

Read More »

Campari Bulls to Get a Serious Hangover Soon

Campari is an Italian liquor and spirits maker with traditions dating back to 1860. The company’s stock price plunged sharply in March along with the markets in general and then recovered just as quickly to new records by year-end. As shares hover near all-time highs, however, dark clouds appear to be gathering over the spirits…

Read More »

More analyses